IGM Biosciences, Inc. Operating Income
IGM Biosciences, Inc. reported Operating Income of $96.26 million for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-07-31.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2025-07-31
- IGM Biosciences, Inc. operating income (loss) for the quarter ending 2025-06-30 was $96.26M.
- IGM Biosciences, Inc. operating income (loss) for the quarter ending 2025-03-31 was -$54.78M.
- IGM Biosciences, Inc. operating income (loss) for the quarter ending 2024-12-31 was -$38.98M.
- IGM Biosciences, Inc. operating income (loss) for the quarter ending 2024-09-30 was -$64.39M.
- IGM Biosciences, Inc. operating income (loss) for fiscal 2024 was -$208.58M.
- IGM Biosciences, Inc. operating income (loss) for fiscal 2023 was -$263.46M.
- IGM Biosciences, Inc. operating income (loss) for fiscal 2022 was -$227.96M.
- IGM Biosciences, Inc. operating income (loss) for fiscal 2021 was -$165.32M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2025-06-30 | $96.26M 10-Q · filed 2025-07-31 | $41.49M 10-Q · filed 2025-07-31 | $2.51M derived: sum of 3 quarters · filed 2025-07-31 | -$61.88M derived: sum of 4 quarters · filed 2025-07-31 |
| 2025-03-31 | -$54.78M 10-Q · filed 2025-05-13 | -$93.76M derived: sum of 2 quarters · filed 2025-05-13 | -$158.14M derived: sum of 3 quarters · filed 2025-05-13 | -$209.50M derived: sum of 4 quarters · filed 2025-07-31 |
| 2024-12-31 | -$38.98M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | -$103.37M derived: sum of 2 quarters · filed 2025-03-06 | -$154.72M derived: sum of 3 quarters · filed 2025-07-31 | -$208.58M 10-K · filed 2025-03-06 |
| 2024-09-30 | -$64.39M 10-Q · filed 2024-11-08 | -$115.74M derived: sum of 2 quarters · filed 2025-07-31 | -$169.60M 10-Q · filed 2024-11-08 | -$234.72M derived: sum of 4 quarters · filed 2025-07-31 |
| 2024-06-30 | -$51.36M 10-Q · filed 2025-07-31 | -$105.21M 10-Q · filed 2025-07-31 | -$170.33M derived: sum of 3 quarters · filed 2025-07-31 | -$237.09M derived: sum of 4 quarters · filed 2025-07-31 |
| 2024-03-31 | -$53.86M 10-Q · filed 2025-05-13 | -$118.97M derived: sum of 2 quarters · filed 2025-05-13 | -$185.74M derived: sum of 3 quarters · filed 2025-05-13 | -$253.94M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | -$65.12M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | -$131.88M derived: sum of 2 quarters · filed 2025-03-06 | -$200.09M derived: sum of 3 quarters · filed 2025-03-06 | -$263.46M 10-K · filed 2025-03-06 |
| 2023-09-30 | -$66.76M 10-Q · filed 2024-11-08 | -$134.97M derived: sum of 2 quarters · filed 2024-11-08 | -$198.34M 10-Q · filed 2024-11-08 | -$254.61M derived: sum of 4 quarters · filed 2025-03-06 |
| 2023-06-30 | -$68.21M 10-Q · filed 2024-08-14 | -$131.58M 10-Q · filed 2024-08-14 | -$187.85M derived: sum of 3 quarters · filed 2025-03-06 | -$248.36M derived: sum of 4 quarters · filed 2025-03-06 |
| 2023-03-31 | -$63.37M 10-Q · filed 2024-05-08 | -$119.64M derived: sum of 2 quarters · filed 2025-03-06 | -$180.15M derived: sum of 3 quarters · filed 2025-03-06 | -$239.37M derived: sum of 4 quarters · filed 2025-03-06 |
| 2022-12-31 | -$56.26M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | -$116.78M derived: sum of 2 quarters · filed 2025-03-06 | -$176.00M derived: sum of 3 quarters · filed 2025-03-06 | -$227.96M 10-K · filed 2025-03-06 |
| 2022-09-30 | -$60.51M 10-Q · filed 2023-11-13 | -$119.74M derived: sum of 2 quarters · filed 2023-11-13 | -$171.69M 10-Q · filed 2023-11-13 | -$222.37M derived: sum of 4 quarters · filed 2024-03-07 |
| 2022-06-30 | -$59.22M 10-Q · filed 2023-08-03 | -$111.18M 10-Q · filed 2023-08-03 | -$161.86M derived: sum of 3 quarters · filed 2024-03-07 | -$206.06M derived: sum of 4 quarters · filed 2024-03-07 |
| 2022-03-31 | -$51.96M 10-Q · filed 2023-05-12 | -$102.64M derived: sum of 2 quarters · filed 2024-03-07 | -$146.84M derived: sum of 3 quarters · filed 2024-03-07 | -$185.57M derived: sum of 4 quarters · filed 2024-03-07 |
| 2021-12-31 | -$50.68M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | -$94.88M derived: sum of 2 quarters · filed 2024-03-07 | -$133.62M derived: sum of 3 quarters · filed 2024-03-07 | -$165.32M 10-K · filed 2024-03-07 |
| 2021-09-30 | -$44.20M 10-Q · filed 2022-11-03 | -$82.94M derived: sum of 2 quarters · filed 2022-11-03 | -$114.64M 10-Q · filed 2022-11-03 | -$139.38M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | -$38.74M 10-Q · filed 2022-08-08 | -$70.44M 10-Q · filed 2022-08-08 | -$95.18M derived: sum of 3 quarters · filed 2022-08-08 | -$115.74M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | -$31.71M 10-Q · filed 2022-05-09 | -$56.45M derived: sum of 2 quarters · filed 2022-05-09 | -$77.01M derived: sum of 3 quarters · filed 2022-05-09 | -$96.41M derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | -$24.74M 10-K · filed 2021-03-30 | -$45.30M derived: sum of 2 quarters · filed 2021-11-04 | -$64.71M derived: sum of 3 quarters · filed 2021-11-04 | -$83.28M 10-K · filed 2023-03-30 |
| 2020-09-30 | -$20.56M 10-Q · filed 2021-11-04 | -$39.97M derived: sum of 2 quarters · filed 2021-11-04 | -$58.54M 10-Q · filed 2021-11-04 | -$74.48M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | -$19.41M 10-Q · filed 2021-08-09 | -$37.98M 10-Q · filed 2021-08-09 | -$53.92M derived: sum of 3 quarters · filed 2021-08-09 | -$64.59M derived: sum of 4 quarters · filed 2021-08-09 |
| 2020-03-31 | -$18.57M 10-Q · filed 2021-05-06 | -$34.51M derived: sum of 2 quarters · filed 2021-05-06 | -$45.18M derived: sum of 3 quarters · filed 2021-05-06 | -$55.71M derived: sum of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | -$15.94M 10-K · filed 2021-03-30 | -$26.61M derived: sum of 2 quarters · filed 2021-03-30 | -$37.14M derived: sum of 3 quarters · filed 2021-03-30 | -$44.50M 10-K · filed 2022-03-29 |
| 2019-09-30 | -$10.67M 10-K · filed 2021-03-30 | -$21.20M derived: sum of 2 quarters · filed 2021-03-30 | -$28.56M 10-Q · filed 2020-11-05 | -$37.61M derived: sum of 4 quarters · filed 2021-03-30 |
| 2019-06-30 | -$10.53M 10-K · filed 2021-03-30 | -$17.89M 10-Q · filed 2020-08-06 | -$26.93M derived: sum of 3 quarters · filed 2021-03-30 | -$33.48M derived: sum of 4 quarters · filed 2021-03-30 |
| 2019-03-31 | -$7.36M 10-K · filed 2021-03-30 | -$16.40M derived: sum of 2 quarters · filed 2021-03-30 | -$22.95M derived: sum of 3 quarters · filed 2021-03-30 | -$27.19M derived: sum of 4 quarters · filed 2021-03-30 |
| 2018-12-31 | -$9.05M 10-K · filed 2020-03-26 | -$15.59M derived: sum of 2 quarters · filed 2020-03-26 | -$19.84M derived: sum of 3 quarters · filed 2020-03-26 | -$22.79M 10-K · filed 2021-03-30 |
| 2018-09-30 | -$6.54M 10-K · filed 2020-03-26 | -$10.79M derived: sum of 2 quarters · filed 2020-03-26 | -$13.74M 10-Q · filed 2019-11-07 | |
| 2018-06-30 | -$4.24M 10-K · filed 2020-03-26 | -$7.20M derived: sum of 2 quarters · filed 2020-03-26 | ||
| 2018-03-31 | -$2.96M 10-K · filed 2020-03-26 | |||
| 2017-12-31 | -$11.15M 10-K · filed 2020-03-26 |